Increasing incidence of gastrointestinal disorders, growing global geriatric population, and rising awareness regarding gastrointestinal health are key factors driving market growth.
Increasing incidence of gastrointestinal disorders, growing global geriatric population, and rising awareness regarding gastrointestinal health are key factors driving market growth
The global digestive enzymes market size is expected to reach USD 1,319.8 Million in 2028 at a CAGR of 10.3%, according to the latest report by Reports and Data. Rising awareness of gastrointestinal disorders, increasing focus on maintaining gastrointestinal health, and rapid launch of advanced products are key factors expected to drive market revenue growth over the forecast period. In addition, there is a high prevalence of digestive disorders and gastric discomfort among aged population as secretion of digestive enzymes decreases with age, which is further contributing to increased demand for digestive enzymes and supplements. This is another key factor expected to fuel revenue growth of the market going ahead.
Digestive enzymes are secreted by salivary glands and cells that line the stomach, pancreas, and small intestine that aid in breakdown and digestion of food. Digestive enzymes breakdown the large and complex macronutrients into smaller ones which facilitates easy absorption of nutrients from these foods into the bloodstream. Different types of digestive enzymes target different nutrients such as amylase breaks down starch and carbohydrates, protease targets proteins, and lipase acts on fats. Lack of these digestive enzymes can result in poor digestion and malnutrition leading to a variety of gastrointestinal (GI) symptoms. In such cases, digestive enzyme replacement is necessary and some digestive enzymes may require prescription while some are available over-the-counter.
Digestive enzyme pills, powders, and liquids that are extensively sold in pharmacies or health and nutrition stores effectively ease digestive disorder symptoms and this has been boosting its demand among geriatric population. In addition, rising popularity of digestive enzymes supplements in sports nutrition owing its benefits such as improved athletic performance, enhanced endurance, and growing need to prevent digestive stress during training has been boosting its demand among sports professionals and this is also a key factor expected to support market growth going ahead. However, growing preference for probiotics over digestive enzymes, ethical issues surrounding animal-derived enzymes, and low reliability of over-the-counter supplements are expected to hamper market growth to a certain extent over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1251
Some Key Highlights from the Report:
- Tablets segment accounted for the largest revenue share in the global market in 2020 and is expected to register significant revenue growth over the forecast period. Revenue growth can be attributed to increasing ability of tablets to optimize breakdown of macronutrients, promote optimal nutrient absorption, and availability of wide range of tablets in pharmacies and nutrition stores.
- Carbohydrates segment is expected to register robust revenue CAGR over the forecast period owing to growing demand for amylase supplements. Carbohydrates are excessively consumed as they provide energy to the body and are essential for a broad range of functions such as from normal cell functioning to cell growth and repair. Amylase aids in breakdown of carbohydrates so that they can be easily absorbed in the body and the levels of this enzyme are often used in the diagnosis of pancreatic and digestive tract disorders, which is driving demand for the product and is expected to support revenue growth of this segment.
- Animal-origin segment is expected to dominate other segments over the forecast period owing to increasing efficiency of these supplements in treatment of various diseases and conditions such as pancreatitis, pancreatic cancer, and inadequate production of pancreatic amylase.
- Increasing demand for digestive enzyme supplements among sports professionals and athletes to improve performance and endurance is a key factor driving revenue growth of the sports nutrition segment.
- Asia Pacific market revenue is expected to expand at a CAGR of 12.4% during the forecast period owing to rising incidence of digestive disorders due to changing lifestyle habits, growing geriatric population, and increasing research and development activities to produce more advanced digestive enzyme supplements.
- Key companies in the market include AbbVie Inc., Allergan PLC, Johnson & Johnson Inc., Country Life LLC., National Enzyme Company, Rainbow Light Nutritional Systems Inc., Garden Of Life Inc., Biotics Research Corporation, Food State Inc., Matsun Nutrition, Metagenics, Inc., Twinlab Corporation, and Abbott Nutrition.
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1251
For the purpose of this report, Reports and Data has segmented the global digestive enzymes market on the basis of dosage form, product type, origin, application, and region:
Dosage form Outlook (Revenue, USD Million; Volume, Kilo tons; 2018-2028)
- Tablets
- Capsules
- Powder
- Liquids
- Others
Product type Outlook (Revenue, USD Million; Volume, Kilo tons; 2018-2028)
- Carbohydrates
- Protease
- Lipase
- Others
Origin Outlook (Revenue, USD Million; Volume, Kilo tons; 2018-2028)
- Animal
- Fungi
- Microbial
- Plant
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1251
Application Outlook (Revenue, USD Million; Volume, Kilo tons; 2018-2028)
- Infant Nutrition
- Medical Nutrition
- Sports Nutrition
- Others
Regional Outlook (Revenue, USD Million; Volume, Kilo tons; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Israel
- South Africa
- Rest of Middle East & Africa
Explore Reports and Data’s Prime Analysis of the global Pharma & Healthcare Industry:
Digital Prescription Technology Market Size, Growth & Analysis, By Product, (Integrated Solutions, Standalone Solutions, Service) By Delivery Mode (Web, Cloud, On-premise), and By End-User (Office-based Physicians, Hospital, Pharmacy), Forecasts to 2027
Autologous Cell Therapy Product Market by Source (Bone Marrow Epidermis), By End-User (Hospitals, Ambulatory Centers, Research Centers) and By Application (Cancer, Neurodegenerative Diseases), And Segment Forecasts to 2027
Metformin Hydrochloride Market Size, Trend and Growth By Type (Metformin HCL, Metformin DC, Others), Application Type (Metformin Hydrochloride Tablets, Metformin Hydrochloride Extended-Release Tablets, Others), And Region- Global Forecast To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-digestive-enzyme-market